CVS Health cuts FY24 adjusted EPS view to at least $8.30 from at least $8.50

Consensus $8.50. Cuts FY24 cash flow from operations view to at least $12B from $12.5B. The company said, “The Company’s guidance revision follows a review of its recently finalized medical cost trend analysis for the fourth quarter of 2023 and the potential implications for elevated medical cost trends in 2024.”